Overview
Yongwen Li practices in Tianjin, China. Li is rated as an Advanced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 73 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Lung Metastases.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung Cancer
- Lung Adenocarcinoma
- Lung CancerLi isAdvanced. Learn about Lung Cancer.
- Lung MetastasesLi isAdvanced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Cerebral HypoxiaLi isExperienced. Learn about Cerebral Hypoxia.
- NecrosisLi isExperienced. Learn about Necrosis.
- Neuroendocrine TumorLi isExperienced. Learn about Neuroendocrine Tumor.
- RetinoblastomaLi isExperienced. Learn about Retinoblastoma.
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma